Clinical Trial

A Data Collection Protocol to Evaluate the Real World Usage of the Orthofix AccelStim Device to Treat Fresh Metatarsal Fractures

Study acronym: ASRW
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 29, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study examines the effect of using the AccelStim bone growth stimulator on subjects undergoing treatment for fresh metatarsal fractures.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-03.
Trial Details
NCT Number NCT07286357
Lead Sponsor Orthofix Inc.
Conditions Metatarsal Fracture
Enrollment 100 participants
Start Date 2025-05-30
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-29